Sarepta Therapeutics (SRPT) Q2 2026 Earnings

6MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-4.6
-2.11
0.39
2.88

Details

Expected EPS
0.975922
Actual EPS
2.88
Surprise EPS
1.9
Surprise Percent
+195.11%

Description

Sarepta Therapeutics (SRPT) has reported earnings of 2.88 per share for Q2 2026.

0 Comments

Share your thoughts